Ligand validation:5FPL

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FPL_EDO_A_1756	57%	81%	0.174	0.95	0.52	0.3	-	-	0	0	100%	1
5FPL_EDO_A_1755	47%	77%	0.183	0.923	0.83	0.1	-	-	0	0	100%	0.74
5FYZ_EDO_A_1766	98%	84%	0.067	0.986	0.5	0.26	-	-	0	0	100%	1
5FYS_EDO_A_1766	97%	78%	0.061	0.977	0.5	0.39	-	-	0	0	100%	1
5FZA_EDO_A_1765	97%	86%	0.074	0.987	0.52	0.21	-	-	0	0	100%	1
5A3P_EDO_A_1769	96%	81%	0.085	0.992	0.5	0.32	-	-	0	0	100%	1
5FZ8_EDO_A_1766	95%	85%	0.079	0.982	0.52	0.24	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.7
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.